Peripheral blood progenitor uncontrolled-rate freezing: a single pediatric center experience

被引:5
|
作者
Iannalfi, Alberto [1 ]
Bambi, Franco [1 ]
Tintori, Veronica [1 ]
Lacitignola, Laura [1 ]
Bernini, Gabriella [1 ]
Mariani, Maria Pia [1 ]
Sanvito, Maria Chiara [1 ]
Pagliai, Francesca [1 ]
Brandigi, Francesco [1 ]
Muscarella, Elisa [1 ]
Tapinassi, Francesca [1 ]
Faulkner, Lawrence [1 ]
机构
[1] Univ Florence, A Meyer Pediat Hosp, Dept Hematol & Oncol, Stem Cell Transplant Unit, I-50121 Florence, Italy
关键词
D O I
10.1111/j.1537-2995.2007.01447.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Controlled-rate freezing (CRF) followed by storage in liquid nitrogen is employed by most centers as the standard procedure for peripheral blood progenitor cell (PBPC) cryopreservation. Uncontrolled-rate freezing (URF) at -80 degrees C is more simple, time-saving, less expensive, and, possibly, as effective as CRF. The aim of this retrospective analysis was to compare CRF and URF in childhood transplantation. STUDY DESIGN AND METHODS: A total of 54 PBPC transplants performed in 39 children aged 3 to 16 years (median, 9.5 years) were analyzed: 23 transplants in 16 children with CRF versus 31 transplants performed in 23 children with -80 degrees C URF. All grafts contained at least 2 x 10(6) per kg unselected CD34+ cells, enumerated before freezing. Nucleated cells infused ranged from 1.32 x 10(8) to 4.3 x 10(8) per mL with a median of 3.1 x 10(8) per mL. Cryoprotectant solution consisted of a final dimethyl sulfoxide (DMSO) concentration of 10 percent DMSO with autologous plasma. RESULTS: The two study groups did not differ in terms of timing of neutrophil and platelet recovery or transfusion requirements. Adverse events related to graft infusion, severe complications, and transplant-related mortality were not significantly different between CRF and URF groups. In both groups only mild adverse events were observed during graft administration. URF procedures, however, were simpler and less expensive. At a median follow-up of 72 months, no secondary myelodysplasia was observed in either group. CONCLUSION: Our analysis suggests that URF is safe and effective in the pediatric population.
引用
收藏
页码:2202 / 2206
页数:5
相关论文
共 50 条
  • [21] Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: a single center experience
    Carlo Castagnola
    Emilio Alessandrino
    Monia Lunghi
    Paolo Bernasconi
    Matteo Della Porta
    Silvia Mangiacavalli
    Anna Colombo
    Alessandro Corso
    Guido Pagnucco
    Mario Lazzarino
    Carlo Bernasconi
    Annals of Hematology, 2001, 80 : 267 - 271
  • [22] Transplantation of allogeneic peripheral blood progenitor cells -: A single centre experience
    Vítek, A
    Sajdová, J
    Hrabánek, J
    Kobylka, P
    Korínková, P
    Gasová, Z
    Loudová, M
    Cukrová, V
    Dolezalová, L
    Marinov, J
    Sieglová, Z
    Hrubá, A
    BONE MARROW TRANSPLANTATION, 1998, 22 : S73 - S76
  • [23] COMPARATIVE-ANALYSIS OF ENGRAFTMENT AFTER CRYOPRESERVATION OF PERIPHERAL-BLOOD STEM-CELL AUTOGRAFTS BY CONTROLLED-RATE VERSUS UNCONTROLLED-RATE METHODS
    TAKAUE, Y
    ABE, T
    KAWANO, Y
    SUZUE, T
    SAITO, S
    HIRAO, A
    SATO, J
    MAKIMOTO, A
    KAWAHITO, M
    WATANABE, T
    SHIMOKAWA, T
    KURODA, Y
    BONE MARROW TRANSPLANTATION, 1994, 13 (06) : 801 - 804
  • [24] Cryopreservation of Peripheral Blood Progenitor Cells By Uncontrolled Rate Freezing at-95 C Using Cryoprotectant Containing a Final Concentration of 5 Percent Dimethyl Sulfoxide
    Cooper, L.
    Parameswaran, R.
    Serrano, L.
    Travers, H.
    TRANSFUSION, 2010, 50 : 224A - 225A
  • [25] Peripheral blood progenitor cells collection in healthy donors for allogeneic transplantation: experience of a single center with large volume leucapheresis
    Alegre, A.
    Aguado, B.
    Camara, C.
    Gomez, V.
    Figuera, A.
    Royg, M.
    Garca Fernandez, N.
    Velasco, A.
    Quereda, B.
    Acedo, N.
    Cuadrado, M.
    Garcia Leon, N.
    Martinez, S.
    Fernandez-Villalta, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S356 - S356
  • [26] COLLECTION OF PERIPHERAL BLOOD HEMATOPOIETIC PROGENITOR CELLS (PBPC) FROM HEALTHY DONORS: 15 YEARS SINGLE CENTER EXPERIENCE
    Aguado, B.
    Jimenez Barral, E.
    Arriero, A.
    Cornago, J.
    Paz, Y.
    Vicuna, I.
    Gomez, V.
    de la Camara, R.
    Figuera, A.
    Alegre, A.
    HAEMATOLOGICA, 2017, 102 : 637 - 637
  • [27] Contamination Rate of Hematopoietic Progenitor Products ... .a Single Tertiary Care Center Experience
    Alhumaidan, Hind
    AlSeraihy, Amal
    Simons, Yiskah
    Alalem, Sahar
    Badawi, Muhammad
    Yaghmour, Manal
    TRANSFUSION, 2018, 58 : 79A - 80A
  • [28] Allogeneic transplantation of peripheral blood progenitor cells in children: experience of two pediatric centers
    Miniero, R
    Busca, A
    Bonetti, F
    Giorgiani, G
    Zecca, M
    Berger, M
    Incarbone, E
    Vassallo, E
    Perotti, C
    Locatelli, F
    BONE MARROW TRANSPLANTATION, 1998, 22 : S33 - S36
  • [29] Graft survival rate in pediatric renal transplantation: A single center experience
    Almasi-Hashiani, Amir
    Rajaeefard, Abdolreza
    Hassanzade, Jafar
    Salahi, Heshmatollah
    Mehrabani, Davood
    Khedmati, Esmaeil
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2012, 28 (05) : 806 - 811
  • [30] The use of plerixafor in hematopoietic progenitor cell collection in pediatric patients: a single center experience
    Pham, Huy P.
    Patel, Nita
    Semedei-Pomales, Mildred
    Bhatia, Monica
    Schwartz, Joseph
    CYTOTHERAPY, 2012, 14 (04) : 467 - 472